Endocrine Pathology

Familial Nonmedullary Thyroid Neoplasia
pp. 97-112(16)
Author: Harach H.R.

High Prevalence of RET Tyrosine Kinase Activation in Mexican Patients with Papillary Thyroid Carcinomas
pp. 113-123(11)
Authors: Martínez I.; Mantilla A.; Medrano M.E.; Hernández R.; Hernández D.M.; Lazos M.; Santiago H.; González B.; Hidalgo A.; Salcedo M.

Analysis of -Catenin Mutations and -, -, and -Catenin Expression in Normal and Neoplastic Human Pituitary Tissues
pp. 125-136(12)
Authors: Tziortzioti V.; Ruebel K.H.; Kuroki T.; Jin L.; Scheithauer B.W.; Lloyd R.V.

Immunocytochemical Localization of Prohormone Convertase 1/3 and 2 in Gastrointestinal Carcinoids
pp. 137-145(9)
Author: Tomita T.

Somatostatin Type 2A Receptor Immunoreactivity in Human Pancreatic Adenocarcinomas
pp. 147-155(9)
Authors: Pilichowska M.; Kimura N.; Schindler M.; Kobari M.

Paucicellular Variant of Anaplastic Thyroid Carcinoma: Report of Two Cases
pp. 157-161(5)
Authors: Carles Canos J.; Serrano A.; Matias-Guiu X.

Correlation Between PCNA Expression and AgNOR Dots in Pituitary Adenomas
pp. 163-169(7)
Authors: Klencki M.; Kurnatowska I.; Slowinska-Klencka D.; Lewinski A.; Pawlikowski M.

GH-, PRL-, POMC-, -TSH-, -LH-, -FSH-mRNA in Gonadotroph Adenomas of the Pituitary by In Situ Hybridization in Comparison with Immunostaining and Clinical Data
pp. 171-180(10)
Authors: Münscher A.; Schmid M.; Saeger W.; Schreiber S.; Lüdecke D.K.

The Eighth Meeting of the International Pituitary Pathology Club
pp. 191-254(64)
Author: .